Today at #AACR26, our CEO and Co-Founder David Chang, MD, PhD, will share how #allogenenic #CAR T is uniquely positioned to overcome today's barriers to autologous treatments, and be delivered at biologic-like scale to reach more patients, faster. #celltherapy $ALLO

Learn More: https://t.co/FRMq8VtPCF